Cell and organ transplants can be lifesaving, but patients often encounter long waiting lists due to the shortage of suitable donors.
Monovalent vaccine outperforms bivalent in fighting new Omicron variants
New U.S. study finds mRNA-1273.815, a monovalent vaccine targeting the Omicron XBB.1.5 variant, generates higher neutralizing antibody titers compared to its bivalent counterpart. The study
September 6, 2023